EichorEICHOR
Location: Hartford Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Hartford

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Connecticut Children's Medical Center · National Cancer Institute (NCI) · NCT05099003Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Connecticut Children's Medical Center · National Cancer Institute (NCI) · NCT06172296Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · Hartford Health Hospital · University of Cincinnati · NCT05911568Army-SPRING Army-Suicide Prevention Research
Phase 1 · Connecticut Army National Guard · University of Pennsylvania · NCT06547008Target ADHD Executive Working Memory Replication Study
NA · Institute of Living/Hartford Hospital · Hartford Hospital · NCT06446284A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hartford Hospital · Hoffmann-La Roche · NCT06793215A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Phase 2 · Hartford Healthcare Alliance (Data Collection Only) · Memorial Sloan Kettering Cancer Center · NCT06594991A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Connecticut Children's Medical Center · Children's Oncology Group · NCT06368817A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Phase 2 · Hartford Healthcare Alliance (Data collection only) · City of Hope Medical Center · NCT05751434A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Connecticut Children's Medical Center · National Cancer Institute (NCI) · NCT05691478Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Connecticut Children's Hospital · Giselle Sholler · NCT02559778Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832StrokeNet Thrombectomy Endovascular Platform
NA · Hartford Hospital · Medical University of South Carolina · NCT06289985Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Hartford Hospital (HH) · Eli Lilly and Company · NCT06890598rTMS as Add on Treatment for Substance Use Disorders
NA · Hartford Healthcare · Yale University · NCT06963476A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Connecticut Children's Medical Center · Children's Oncology Group · NCT04322318OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?
NA · Connecticut Children's Medical Center · Connecticut Children's Medical Center · NCT05911646A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Amgen · NCT07005128Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Saint Francis · NRG Oncology · NCT05174169Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
Phase 2 · Hartford Healthcare (Data Collection) · Memorial Sloan Kettering Cancer Center · NCT04165772Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Hartford HealthCare Cancer Institute · Kura Oncology, Inc. · NCT07007312Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I
Phase 3 · Alkermes Investigator Site · Alkermes, Inc. · NCT05303064A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Hartford HealthCare · Bristol-Myers Squibb · NCT05489705VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/Phase 2 · Hartford Hospital (site 210) · VM Oncology, LLC · NCT03556228ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Smilow Cancer Hospital Care Center at Saint Francis · Alliance for Clinical Trials in Oncology · NCT06876714A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · Hartford Healthcare · BioNTech SE · NCT07070232Pain and Weight Treatment: Development and Trial of PAW
NA · Connecticut Children's Medical Center · Connecticut Children's Medical Center · NCT04046562Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty
Phase 2 · Trinity Health Of New England/CT Joint Replacement Institute · Matthew Grosso, MD · NCT06479161Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance
Phase N/A · Hartford Hospital · Yale University · NCT05907629A Study to Assess Growth in Children With Idiopathic Short Stature
Phase N/A · Connecticut Children's Medical Center · BioMarin Pharmaceutical · NCT06309979
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.